{"id":2085,"date":"2020-09-28T21:27:38","date_gmt":"2020-09-28T21:27:38","guid":{"rendered":"https:\/\/alshahba-pharma.com\/?p=2085"},"modified":"2020-10-29T10:45:56","modified_gmt":"2020-10-29T10:45:56","slug":"furosemide-alshahba-500","status":"publish","type":"post","link":"https:\/\/alshahba-pharma.com\/en\/2020\/09\/28\/furosemide-alshahba-500\/","title":{"rendered":"Furosemide Alshahba 500"},"content":{"rendered":"

Furosemide Alshahba 500<\/h2><\/div>

Composition:<\/u><\/strong><\/p>\n

Each tablet contains:<\/p>\n

Furosemide 500mg.<\/p>\n

INDICATIONS<\/u><\/strong>:<\/u><\/strong><\/p>\n

\u00a0<\/strong>Furosemide 500 tablets are destined for use exclusively in patients with severely reduced glomerular filtration (glomerular filtration rate (GFR < 20 ml\/min).<\/p>\n

Furosemide 500 mg Tablets are indicated as a diuretic in the management of oliguria in chronic renal insufficiency.<\/p>\n

DOSAGE AND ADMINISTRATION<\/strong><\/p>\n

Adults and children over 12 years: For cases of chronic renal insufficiency, an initial dose of 250mg (half a tablet) is employed. If a satisfactory diuresis is not achieved then the dose may be increased in steps of 250mg at 4-6 hourly intervals up to a maximum dose of 3 tablets (1.5g) as a single dose in 24 hours. In exceptional cases up to 4 tablets (2g) in 24 hours may be given.<\/p>\n

Pediatric population : The 500 mg strength is not recommended for use in children and adolescents under 18 years of age due to insufficient data on safety and efficacy .<\/span><\/p>\n

Packaging:<\/u><\/strong><\/p>\n

20 tablet.<\/p>\n<\/div>

<\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":2086,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":""},"categories":[40,101,65,75,38],"tags":[],"class_list":["post-2085","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cardiovascular-drugs","category-medicines","category-pharmacologic-form","category-tablets","category-therapeutic-categories"],"_links":{"self":[{"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/posts\/2085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=2085"}],"version-history":[{"count":5,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/posts\/2085\/revisions"}],"predecessor-version":[{"id":3624,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/posts\/2085\/revisions\/3624"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/media\/2086"}],"wp:attachment":[{"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=2085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=2085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alshahba-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=2085"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}